Cho, H., Hyung, J., Eom, H., Lim, S., Kang, H. J., Lee, M., Do, Y. R., Jeong, S. H., Kim, H. J., Koh, Y., Yi, S. Y., Kang, K., Kim, M. K., Kwak, J., Lee, G., Yoon, D. H. (2025). Phase II study of lenalidomide in combination with rituximab, cyclophosphadmie, doxorubicin, vincristine, and prenisone (R-CHOP) for central nervous system prophylaxis in high-risk diffuse large B cell lymphoma. Blood. https://doi.org/10.1182/blood-2025-1915